In particular, 5hmC is significantly downregulated in gliomas, which may be attributed to a mutation in the isocitrate dehydrogenase genes IDH1/2, resulting in either a shortage of TET or the TET cosubstrate α-ketoglutaric acid. The gene discussed is IDH1; the disease is glioma.